The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

The Food and Drug Administration (FDA) announced plans to significantly curtail people’s access to Covid-19 vaccines.

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...

Complicating matters, however, were new FDA rules for the updated Covid vaccines, announced just days earlier, that would ...

Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...